Potential Collaborative Markers for Nasopharyngeal Carcinoma Diagnosis and Therapy: AGR2 and AKR1B10
Clinical Medicine and Pharmacology · 2025
DOI: 10.70731/rek12e38 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine and Pharmacology, 2025. Verfasst von Qi Tang und 3 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nasopharyngeal carcinoma is a prevalent malignant tumor, which lacks specific diagnostic markers and effective therapeutic evaluation indexes. AGR2 (Pregradient protein 2) and AKR1B10 (aldoketone reductase 1B10) are oncoproteins secreted by cancer cells into peripheral blood. Prior researches have suggested that the upregulation of AGR2 and AKR1B10 occurs in both primary and metastatic NPC tissues, indicating their potential as biomarkers for NPC development. In the present study, NPC patients had considerably greater serum levels of AGR2 and AKR1B10 than did healthy persons, and these levels decreased following treatment. Furthermore, the serum concentrations of AGR2 and AKR1B10 in patients with NPC were positively correlated with the grade of TNM (tumor lymph node metastasis) and the occurrence of meta stasis. Consistently, AGR2 and AKR1B10 positive rates in NPC tissues were notably greater than those in nearby normal tissues. Additionally, there was an affirmative linear connection between AGR2 and AKR1B10 in NPC patients. In conclusion, there appears to be a close relationship between the expression of AGR2 and AKR1B10, both serving as synergistic biomarkers for early diagnosis and treatment evaluation indicators for patients with nasopharyngeal carcinoma.
Zitieren
APA
Tang, Q., Wu, Y., Tan, Y., & Tang, F. (2025). Potential Collaborative Markers for Nasopharyngeal Carcinoma Diagnosis and Therapy: AGR2 and AKR1B10. Clinical Medicine and Pharmacology. https://doi.org/10.70731/rek12e38
Vancouver
Tang Q, Wu Y, Tan Y, Tang F. Potential Collaborative Markers for Nasopharyngeal Carcinoma Diagnosis and Therapy: AGR2 and AKR1B10. Clinical Medicine and Pharmacology. 2025. doi:10.70731/rek12e38
BibTeX
@article{Tang2025,
author = {Tang, Qi and Wu, Yao and Tan, Yuan and Tang, Faqing},
title = {Potential Collaborative Markers for Nasopharyngeal Carcinoma Diagnosis and Therapy: AGR2 and AKR1B10},
journal = {Clinical Medicine and Pharmacology},
year = {2025},
doi = {10.70731/rek12e38}
}
EUVIMED